Netherlands· NL-d18a1d897e31
Iberogast Select, vloeistof voor oraal gebruik
A other drugs for functional gastrointestinal disorders product, registered in Netherlands by Bayer B.V.. The same ATC class is registered in 8 of our 19 countries.
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
Where it is registered
Iberogast is registered in 8 of 19 countries.
Countries holding a registration under ATC A03AX (other drugs for functional gastrointestinal disorders), each read from that country’s own register.
- This record: Netherlands, from CBG-MEB (Netherlands)
- 5 of them publish a price we can compare per daily dose
Iberogast · ATC A03AX
8 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Icelandprice
- Ireland
- Netherlands
- Polandprice
- Switzerlandprice
The record
At a glance
CBG-MEB (Netherlands)- Manufacturer
- Bayer B.V.
- Country
- Netherlands (NL)
- ATC code
- A03AX
- ATC class
- Other drugs for functional gastrointestinal disorders
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id129030
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A03AX
Other drugs for functional gastrointestinal disorders, as other registers publish it.
- BelgiumCarmenthin 90 mg - 50 mgDr. Willmar Schwabe
- IrelandColpermin Gastro-resistant Capsules Peppermint oil 0.2mlJNTL Consumer Health I (Ireland) Limited
- CzechiaGASPANDr. Willmar Schwabe GmbH & Co. KG, Karlsruhe
- CzechiaGASPANDr. Willmar Schwabe GmbH & Co. KG, Karlsruhe
- CzechiaGASPANDr. Willmar Schwabe GmbH & Co. KG, Karlsruhe
- CzechiaGASPANDr. Willmar Schwabe GmbH & Co. KG, Karlsruhe
- CzechiaGASPANDr. Willmar Schwabe GmbH & Co. KG, Karlsruhe
- CzechiaGASPANDr. Willmar Schwabe GmbH & Co. KG, Karlsruhe
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/0805c028-1f67-426a-95b0-bd3e99a45fb7 GET /v1/drugs/0805c028-1f67-426a-95b0-bd3e99a45fb7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Druppels voor oraal gebruik, oplossing",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h129030_smpc.pdf",
"strength": null,
"atc_label": "Other drugs for functional gastrointestinal disorders",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg129030",
"excipients": [
"GEEN HULPSTOFFEN"
],
"substances": [
"CARUM CARVI L., FRUCTUS (KARWIJVRUCHT), LIQUID EXTRACT (ETHANOL 30% V-V) (DER 1 = 2.5-3.5)",
"GLYCYRRHIZA GLABRA L. EN/OF GLYCYRRHIZA INFLATA BAT EN/OF GLYCYRRHIZA URALENSA FISCH, RADIX (ZOETHOUTWORTEL), VLOEIBAAR EXTRACT (ETHANOL 30% V-V) (DER 1 = 2.5-3.5)",
"IBERIS AMARA L., PLANTA TOTA RECENS (BITTERE SCHEEFBLOEM), VLOEIBAAR EXTRACT (ETHANOL 50% V-V) (DER 1 = 1.5-2.5)",
"MATRICARIA RECUTITA L., FLOS (ECHTE KAMILLEBLOEM), VLOEIBAAR EXTRACT (ETHANOL 30% V-V) (DER 1=2-4)",
"MELISSA OFFICINALIS L., FOLIUM (BLAD VAN CITROENMELISSE), VLOEIBAAR EXTRACT (ETHANOL 30% V-V) (DER 1=2.5-3.5)",
"MENTHA X PIPERITA L., FOLIUM (BLAD VAN PEPERMUNT), VLOEIBAAR EXTRACT (ETHANOL 30% V-V) (DER 1=2.5-3.5)"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h129030.pdf",
"authorised_at": "2023/06/05",
"procedure_number": "AT/H/1264/001",
"dispensing_status": "Uitsluitend apotheek of drogist",
"registration_number": "129030",
"additional_monitoring": "N"
}See everything about Iberogast.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.